Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Dare Bioscience, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −4 vs. Q1 2022
- Shares held
- 7.42M
- +774.9K (+11.7%) vs. Q1 2022
- Total value
- $9.12M
- −$768.3K (−7.8%) vs. Q1 2022
- New holders
- 5
- 17 more added
- Sold out
- 9
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 3,503,264 | $4.31M | 0.00% | +50,243+1.5% | Added |
| Geode Capital Management, LLC | 715,532 | $880.0K | 0.00% | +16,999+2.4% | Added |
| BlackRock Inc. | 713,989 | $878.0K | 0.00% | +111,953+18.6% | Added |
| Soviero Asset Management, LP | 500,000 | $615.0K | 0.23% | +200,000+66.7% | Added |
| Millennium Management LLC | 445,086 | $547.0K | 0.00% | +189,091+73.9% | Added |
| Renaissance Technologies LLC | 366,600 | $451.0K | 0.00% | +266,261+265.4% | Added |
| State Street Corp | 222,510 | $274.0K | 0.00% | +43,700+24.4% | Added |
| Northern Trust Corp | 161,668 | $199.0K | 0.00% | +20,746+14.7% | Added |
| Founders Financial Securities LLC | 103,500 | $127.0K | 0.02% | +103,500 | New |
| Founders Financial Alliance, LLC | 102,500 | $126.0K | 0.06% | +102,500 | New |
| Interwest Venture Management Co | 62,065 | $76.0K | 0.14% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 62,035 | $76.0K | 0.00% | +32,000+106.5% | Added |
| Price T Rowe Associates Inc | 58,600 | $72.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 52,819 | $65.0K | 0.01% | +52,819 | New |
| Commonwealth Equity Services, LLC | 43,579 | $53.0K | 0.00% | +15,954+57.8% | Added |
| Gsa Capital Partners LLP | 32,350 | $40.0K | 0.01% | −93,604−74.3% | Reduced |
| Charles Schwab Investment Management Inc | 30,532 | $38.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 30,000 | $37.0K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 25,000 | $31.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 25,308 | $31.0K | 0.00% | +2,771+12.3% | Added |
| Tower Research Capital LLC (TRC) | 24,653 | $30.0K | 0.00% | −17,315−41.3% | Reduced |
| Advisor Group Holdings, Inc. | 22,200 | $27.0K | 0.00% | +1,437+6.9% | Added |
| XTX Topco Ltd | 18,846 | $23.0K | 0.01% | −6,989−27.1% | Reduced |
| Advisory Services Network, LLC | 17,000 | $21.0K | 0.00% | +2,000+13.3% | Added |
| Cubist Systematic Strategies, LLC | 16,839 | $21.0K | 0.00% | +16,839 | New |
| United Capital Financial Advisers, LLC | 15,800 | $19.0K | 0.00% | +800+5.3% | Added |
| Insight Financial Services | 11,400 | $14.0K | 0.04% | 00.0% | Unchanged |
| Victory Capital Management Inc | 11,425 | $14.0K | 0.00% | −155−1.3% | Reduced |
| Susquehanna International Group, LLP | 10,403 | $13.0K | 0.00% | +10,403 | New |
| The PNC Financial Services Group, Inc. | 3,400 | $4.00K | 0.00% | +1,000+41.7% | Added |
| Wells Fargo & Company | 2,567 | $3.00K | 0.00% | +95+3.8% | Added |
| Morgan Stanley | 2,649 | $3.00K | 0.00% | +2,503+1,714.4% | Added |
| American Portfolios Advisors | 1,000 | $1.23K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $1.00K | 0.00% | −4,765−90.5% | Reduced |
| Artemis Wealth Advisors, LLC | 881 | $1.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −73,680−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −72,656−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −58,607−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −42,378−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −29,673−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −26,540−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,618−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |